B.Pharm / M. SC in Chemistry / Biotechnology; Experience into Media Fill Activities Exposure into EM Monitoring as QA Knowledge about Sterility, MLT, BET, Water Analysis, Media Preparation; Analysis of Raw Material / Finished product / Intermediates / Stability / Instrumentation / Sampling
M.Pharm or Ph.D. in Pharmacy with industrial experience in pharmaceutical development and scale-up of products. Preferred area of expertise is Oral Dosage forms and Injectable formulations. Perform formulation development activities on differentiated formulations and innovative technologies to achieve Product development.
Ensuring all equipment and materials used in the filling process are properly sterilized and sanitized to maintain aseptic conditions and prevent contamination. Quality Assurance, Conducting in-process checks and inspections to verify product integrity, including visual inspections, measurement checks, and sampling for microbiological testing.
B. Pharm with 2 to 7 years of experience supervising and controlling Packing areas. Should have exposure of handling packing machine PFS, Vial, Cartridge automatic packing line.
Generate sales of company products in the regions through a front line sales team in order to achieve or exceed the annual sales targets. Conduct regular market visits to check route coverage, competitor activity and continuously search for new opportunities in order to increase sales in all the regions
Zydus Life sciences Limited has received final approval from the United States Food and Drug Administration to manufacture Lidocaine and Prilocaine Cream USP.
The U.S. Food and Drug Administration approved Ryoncil remestemcel-L-rknd, an allogeneic donor bone marrow-derived mesenchymal stromal cell therapy indicated for the treatment of steroid-refractory acute graft-versus-host disease SR-aGVHD in pediatric patients 2 months of age and older.
Granules India Limited, a vertically integrated Indian pharmaceutical company, announced today that its wholly-owned foreign subsidiary, Granules Pharmaceuticals, Inc. , has received approval from the U.S. Food & Drug Administration for its Abbreviated New Drug Application for Lisdexamfetamine Dimesylate Chewable Tablets.
Sun Pharma Advanced Research Company Ltd announced the signing of a binding Letter of Intent with the University of California, San Francisco, through the office of OTMA, and Tiller Therapeutics Inc. to license SPARC’s rights in the joint intellectual property held between SPARC and UCSF for pre-clinical oncology asset along with associated IP. The LOI outlines the key terms of license and rights for development and commercialization by Tiller.
M.Pharmor MSc; Integrated Magneto-Acousto-Dielectrophoresis based Microfluidics for the Sorting of Bovine Spermatozoa under Consortium 2 on Bovine Sex semen sorting Technology.
Masters Degree in Pharmacognosy, Botany from a recognized University or equivalent. Working expertise in pharmacognostical and anatomical techniques. Plant based Drug standardization in the field of medicinal plants.
The candidate is required to have working experience in RNA isolation, cDNA synthesis, protein-protein interaction related techniques, microscopy and transcriptome analysis. Prior work experience in the field of root nodule symbiosis and proven publication in the field will be given preference.
Identifying the role of host F-box proteins, a component of E3 ubiquitin ligase complex, in HIV-1 pathogenesis and their potential use as therapeutic target against the virus.
Development and evaluation of oral bait vaccine for classical swine fever in pigs. MVSc. in Biotechnology, Microbiology, Biochemistry or MSc in Biotechnology, Microbiology, Biochemistry, Molecular Biology or B. Tech Biotechnology.
Evaluate the change control requests and the impact on the stability of the products. Review the stability data of the products and issue recommendations for the shelf life Prepare the stability protocols and annual stability summary review for finished products